Featured News
Advancing Cardiovascular Health
Driving Cardiovascular Health Beyond the Lab
Cardiovascular health remains one of the greatest challenges facing patients and healthcare systems today. For Charles River customers developing new therapies, advancing cardiovascular health requires more than scientific progress; it demands a broader commitment to prevention and patient outcomes.
Through our collaboration with the American Heart Association (AHA), Charles River is helping strengthen cardiovascular health initiatives that expand awareness, education, and access to care. By supporting the Heart of Boston campaign, we are contributing to targeted efforts that improve heart disease prevention and community health outcomes.
We are proud to support the prevention, education, and science-driven efforts needed to help sustain progress and improve cardiovascular health worldwide.”
This collaboration reflects our commitment to going beyond the lab to address the underlying drivers of cardiovascular disease. By investing in partnerships that prioritize prevention and public health, we help ensure that scientific innovation translates into real-world impact. These efforts support our customers’ goals by bridging the gap between discovery and patient outcomes, advancing cardiovascular health, and improving lives worldwide.